During the past decade, Taro Pharmaceuticals USA Inc. conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Taro Pharmaceuticals USA Inc." are "Plaque Psoriasis" (4 trials), "Atopic Dermatitis" (2 trials), "Scalp Psoriasis" (2 trials), "Dermatitis, Atopic" (1 trials) and "Lice; Head Lice" (1 trials). Many other conditions were trialed in "Taro Pharmaceuticals USA Inc." in a lesser frequency.

Most popular intervention types in "Taro Pharmaceuticals USA Inc." are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "DSXS" (4 trials), "DSXS topical" (3 trials), "Placebo" (2 trials), "DSXS Topical product" (1 trials) and "DSXS topical product" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taro Pharmaceuticals USA Inc." are 11 trials for "All" genders.

Currently, there are NaN active trials in "Taro Pharmaceuticals USA Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Taro Pharmaceuticals USA Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Taro Pharmaceuticals USA Inc., 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".